Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

Immunovant, Inc. (IMVT)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsMar-31-22Mar-31-21Mar-31-20Mar-31-19
   10-K10-K10-K10-K
Cash flows from operating activities      
Net loss  -156.7-107.4-66.4-28.6
   
Adjustments to reconcile net loss to net cash used in operating activities:      
    Stock-based compensation  34.218.87.01.3
    Depreciation on property and equipment  0.10.10.00.0
    Non-cash lease expense  1.10.9  
    Changes in operating assets and liabilities:      
        Accounts receivable  -11.6-0.6  
        Prepaid expenses and other current assets  2.10.8-2.8-2.5
        Accounts payable  16.31.31.0-0.9
        Accrued expenses  9.54.56.54.9
        Operating lease liabilities  -1.2-0.8  
            Net cash used in operating activities  -106.1-83.3-53.4-28.5
   
Cash flows from investing activities      
Purchase of property and equipment  -0.3-0.20.0-0.1
    Net cash used in investing activities  -0.3-0.20.0-0.1
   
Cash flows from financing activities      
Proceeds from stock options exercised   0.9  
    Net cash provided by financing activities  200.1383.1147.035.6

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy